1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kim, K.-S.
Clark-Lewis, I.
Sykes, B.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
269
32909
32915
7806518
Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy.
1994
10.2210/pdb1msg/pdb
pdb_00001msg
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7763.112
HUMAN MELANOMA GROWTH STIMULATORY ACTIVITY
2
man
polymer
no
no
ASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKNGRKACLNPASPIVKKIIEKMLNSDKS
ASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKNGRKACLNPASPIVKKIIEKMLNSDKS
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1995-03-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1995-01-25
REL
1
BRUNGER
refinement
X-PLOR
ALA
1
n
1
ALA
1
A
SER
2
n
2
SER
2
A
VAL
3
n
3
VAL
3
A
ALA
4
n
4
ALA
4
A
THR
5
n
5
THR
5
A
GLU
6
n
6
GLU
6
A
LEU
7
n
7
LEU
7
A
ARG
8
n
8
ARG
8
A
CYS
9
n
9
CYS
9
A
GLN
10
n
10
GLN
10
A
CYS
11
n
11
CYS
11
A
LEU
12
n
12
LEU
12
A
GLN
13
n
13
GLN
13
A
THR
14
n
14
THR
14
A
LEU
15
n
15
LEU
15
A
GLN
16
n
16
GLN
16
A
GLY
17
n
17
GLY
17
A
ILE
18
n
18
ILE
18
A
HIS
19
n
19
HIS
19
A
PRO
20
n
20
PRO
20
A
LYS
21
n
21
LYS
21
A
ASN
22
n
22
ASN
22
A
ILE
23
n
23
ILE
23
A
GLN
24
n
24
GLN
24
A
SER
25
n
25
SER
25
A
VAL
26
n
26
VAL
26
A
ASN
27
n
27
ASN
27
A
VAL
28
n
28
VAL
28
A
LYS
29
n
29
LYS
29
A
SER
30
n
30
SER
30
A
PRO
31
n
31
PRO
31
A
GLY
32
n
32
GLY
32
A
PRO
33
n
33
PRO
33
A
HIS
34
n
34
HIS
34
A
CYS
35
n
35
CYS
35
A
ALA
36
n
36
ALA
36
A
GLN
37
n
37
GLN
37
A
THR
38
n
38
THR
38
A
GLU
39
n
39
GLU
39
A
VAL
40
n
40
VAL
40
A
ILE
41
n
41
ILE
41
A
ALA
42
n
42
ALA
42
A
THR
43
n
43
THR
43
A
LEU
44
n
44
LEU
44
A
LYS
45
n
45
LYS
45
A
ASN
46
n
46
ASN
46
A
GLY
47
n
47
GLY
47
A
ARG
48
n
48
ARG
48
A
LYS
49
n
49
LYS
49
A
ALA
50
n
50
ALA
50
A
CYS
51
n
51
CYS
51
A
LEU
52
n
52
LEU
52
A
ASN
53
n
53
ASN
53
A
PRO
54
n
54
PRO
54
A
ALA
55
n
55
ALA
55
A
SER
56
n
56
SER
56
A
PRO
57
n
57
PRO
57
A
ILE
58
n
58
ILE
58
A
VAL
59
n
59
VAL
59
A
LYS
60
n
60
LYS
60
A
LYS
61
n
61
LYS
61
A
ILE
62
n
62
ILE
62
A
ILE
63
n
63
ILE
63
A
GLU
64
n
64
GLU
64
A
LYS
65
n
65
LYS
65
A
MET
66
n
66
MET
66
A
LEU
67
n
67
LEU
67
A
ASN
68
n
68
ASN
68
A
SER
69
n
69
SER
69
A
ASP
70
n
70
ASP
70
A
LYS
71
n
71
LYS
71
A
SER
72
n
72
SER
72
A
ALA
1
n
1
ALA
1
B
SER
2
n
2
SER
2
B
VAL
3
n
3
VAL
3
B
ALA
4
n
4
ALA
4
B
THR
5
n
5
THR
5
B
GLU
6
n
6
GLU
6
B
LEU
7
n
7
LEU
7
B
ARG
8
n
8
ARG
8
B
CYS
9
n
9
CYS
9
B
GLN
10
n
10
GLN
10
B
CYS
11
n
11
CYS
11
B
LEU
12
n
12
LEU
12
B
GLN
13
n
13
GLN
13
B
THR
14
n
14
THR
14
B
LEU
15
n
15
LEU
15
B
GLN
16
n
16
GLN
16
B
GLY
17
n
17
GLY
17
B
ILE
18
n
18
ILE
18
B
HIS
19
n
19
HIS
19
B
PRO
20
n
20
PRO
20
B
LYS
21
n
21
LYS
21
B
ASN
22
n
22
ASN
22
B
ILE
23
n
23
ILE
23
B
GLN
24
n
24
GLN
24
B
SER
25
n
25
SER
25
B
VAL
26
n
26
VAL
26
B
ASN
27
n
27
ASN
27
B
VAL
28
n
28
VAL
28
B
LYS
29
n
29
LYS
29
B
SER
30
n
30
SER
30
B
PRO
31
n
31
PRO
31
B
GLY
32
n
32
GLY
32
B
PRO
33
n
33
PRO
33
B
HIS
34
n
34
HIS
34
B
CYS
35
n
35
CYS
35
B
ALA
36
n
36
ALA
36
B
GLN
37
n
37
GLN
37
B
THR
38
n
38
THR
38
B
GLU
39
n
39
GLU
39
B
VAL
40
n
40
VAL
40
B
ILE
41
n
41
ILE
41
B
ALA
42
n
42
ALA
42
B
THR
43
n
43
THR
43
B
LEU
44
n
44
LEU
44
B
LYS
45
n
45
LYS
45
B
ASN
46
n
46
ASN
46
B
GLY
47
n
47
GLY
47
B
ARG
48
n
48
ARG
48
B
LYS
49
n
49
LYS
49
B
ALA
50
n
50
ALA
50
B
CYS
51
n
51
CYS
51
B
LEU
52
n
52
LEU
52
B
ASN
53
n
53
ASN
53
B
PRO
54
n
54
PRO
54
B
ALA
55
n
55
ALA
55
B
SER
56
n
56
SER
56
B
PRO
57
n
57
PRO
57
B
ILE
58
n
58
ILE
58
B
VAL
59
n
59
VAL
59
B
LYS
60
n
60
LYS
60
B
LYS
61
n
61
LYS
61
B
ILE
62
n
62
ILE
62
B
ILE
63
n
63
ILE
63
B
GLU
64
n
64
GLU
64
B
LYS
65
n
65
LYS
65
B
MET
66
n
66
MET
66
B
LEU
67
n
67
LEU
67
B
ASN
68
n
68
ASN
68
B
SER
69
n
69
SER
69
B
ASP
70
n
70
ASP
70
B
LYS
71
n
71
LYS
71
B
SER
72
n
72
SER
72
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
B
O
ALA
50
B
O
ALA
50
B
N
ALA
42
B
N
ALA
42
B
O
GLU
39
B
O
GLU
39
B
N
LYS
29
B
N
LYS
29
B
O
VAL
26
B
O
VAL
26
A
N
VAL
28
A
N
VAL
28
A
O
SER
25
A
O
SER
25
A
N
THR
43
A
N
THR
43
A
O
ALA
42
A
O
ALA
42
A
N
ALA
50
A
N
ALA
50
1
A
A
O
H
LYS
LYS
61
65
1.57
1
B
B
O
H
LYS
LYS
61
65
1.57
1
A
ARG
8
0.317
SIDE CHAIN
1
A
ARG
48
0.316
SIDE CHAIN
1
B
ARG
8
0.317
SIDE CHAIN
1
B
ARG
48
0.316
SIDE CHAIN
1
A
THR
5
-95.96
56.17
1
A
GLU
6
-165.11
92.95
1
A
CYS
11
-33.54
134.65
1
A
GLN
13
-170.27
42.61
1
A
THR
14
30.08
96.43
1
A
PRO
20
-75.75
-122.13
1
A
LYS
21
74.21
-50.34
1
A
ILE
23
-45.68
107.38
1
A
PRO
33
-73.07
-158.84
1
A
ALA
36
33.05
44.03
1
A
THR
38
-64.93
-163.55
1
A
VAL
40
-154.59
71.36
1
A
ARG
48
-109.17
-168.35
1
A
ASN
68
-71.50
-97.10
1
A
SER
69
56.86
71.74
1
B
THR
5
-96.66
56.48
1
B
GLU
6
-165.71
92.16
1
B
CYS
11
-25.65
130.63
1
B
GLN
13
-171.63
42.40
1
B
THR
14
29.78
96.69
1
B
PRO
20
-75.97
-122.04
1
B
LYS
21
74.15
-50.42
1
B
ILE
23
-45.77
107.46
1
B
PRO
33
-72.92
-159.64
1
B
ALA
36
36.95
40.95
1
B
THR
38
-65.35
-163.40
1
B
VAL
40
-154.51
71.84
1
B
ARG
48
-109.07
-168.35
1
B
ASN
68
-71.45
-97.29
1
B
SER
69
57.21
72.95
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY
1
N
N
1
N
N
A
PRO
57
A
PRO
57
HELX_P
A
LEU
67
A
LEU
67
1
1
11
B
PRO
57
B
PRO
57
HELX_P
B
LEU
67
B
LEU
67
1
2
11
disulf
2.023
A
CYS
9
A
SG
CYS
9
1_555
A
CYS
35
A
SG
CYS
35
1_555
disulf
2.023
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
51
A
SG
CYS
51
1_555
CYTOKINE (CHEMOTACTIC)
CYTOKINE (CHEMOTACTIC)
GROA_HUMAN
UNP
1
1
P09341
MARAALSAAPSNPRLLRVALLLLLLVAAGRRAAGASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKN
GRKACLNPASPIVKKIIEKMLNSDKSN
35
106
1MSG
1
72
P09341
A
1
1
72
35
106
1MSG
1
72
P09341
B
1
1
72
6
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
B
LYS
49
B
LYS
49
B
CYS
51
B
CYS
51
B
GLU
39
B
GLU
39
B
THR
43
B
THR
43
B
SER
25
B
SER
25
B
LYS
29
B
LYS
29
A
SER
25
A
SER
25
A
LYS
29
A
LYS
29
A
GLU
39
A
GLU
39
A
THR
43
A
THR
43
A
LYS
49
A
LYS
49
A
CYS
51
A
CYS
51
1
P 1